Predictive value and clinical utility of centrally assessed ER, PgR, and Ki-67 to select adjuvant endocrine therapy for premenopausal women with hormone receptor-positive, HER2-negative early breast cancer: TEXT and SOFT trials
中心评估的ER、PgR和Ki-67在选择激素受体阳性、HER2阴性的绝经前早期乳腺癌女性辅助内分泌治疗中的预测价值和临床应用价值：TEXT和SOFT试验
期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-015-3612-z
Regan, Meredith M; Pagani, Olivia; Francis, Prudence A; Fleming, Gini F; Walley, Barbara A; Kammler, Roswitha; Dell'Orto, Patrizia; Russo, Leila; Szőke, János; Doimi, Franco; Villani, Laura; Pizzolitto, Stefano; Öhlschlegel, Christian; Sessa, Fausto; Peg Cámara, Vicente; Rodríguez Peralto, José Luis; MacGrogan, Gaëtan; Colleoni, Marco; Goldhirsch, Aron; Price, Karen N; Coates, Alan S; Gelber, Richard D; Viale, Giuseppe
Ki-67
肿瘤
HER2
肿瘤免疫
信号转导
乳腺癌
免疫/内分泌
